Possible mutations that may arise in the presence of inhibitors at different concentrations.

*This indicates that this drug at this concentration cannot kill the un-mutated Native (or wild-type) cell.
The rows define the particular point-mutations and the columns define the inhibitors imatinib (I), nilotinib (N), dasatinib (D), and SGX70393 (S), with the indicated concentration (L, M, and H for Low, Medium and High, respectively). A “+” indicates that the mutant is resistant.